the weight loss arena with






Vivus Inc., Orexigen Therapeutics Inc. and Arena Pharmaceuticals Inc. are in a race to bring the first weight loss pill to the market in 13 years. An advisory panel .
From Yahoo! News: (Reuters) - Arena Pharmaceuticals Inc said on Tuesday it submitted an official response addressing safety concerns of U.S. health regulators over the company .
Views on UGA Athletics, college football, life, or whatever else strikes our fancy.
(Reuters) - Arena Pharmaceuticals Inc said on Tuesday it submitted the weight loss arena with an official response addressing safety the weight loss arena with concerns of U.S. health regulators over the company's .
Will a new weight loss drug be approved in 2012? Here we are, two months into 2012 and the
FDA has another opportunity to approve a new drug to help fight obesity. Will this be .
SAN DIEGO (AP)
Tomorrow is the deadline for the Food and Drug Administration to make a decision about whether or not to approve Arena Pharmaceuticals' experimental obesity
Arena Pharmaceuticals and partner Eisai are hopeful regulators will look kindly on its obesity drug lorcaserin after responding to a rejection issued by the US Food and Drug .
Weight Loss Surgery for Diabetes Patients
WASHINGTON
Read 'Arena says addressed FDA concerns on weight loss drug' on Yahoo! News UK. (Reuters) - Arena Pharmaceuticals Inc said on Tuesday it submitted data to health regulators .
SAN DIEGO
Arena Pharmaceuticals Inc. (ARNA) and Eisai Co. said a study showed that concentrations of their weight-loss pill were lower in human brains than in rat models, a .
Arena Pharmaceuticals Inc said on Saturday U.S. health officials have rejected its
sources: